These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 6452794)

  • 1. Controlled cross-over study of a 5-HT uptake inhibiting and an NA uptake inhibiting antidepressant.
    Aberg A
    Acta Psychiatr Scand Suppl; 1981; 290():244-55. PubMed ID: 6452794
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. I. Clinical findings.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Jul; 66(1):50-65. PubMed ID: 6214925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a noradrenaline uptake inhibitor, in endogenous depression. II. Biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Acta Psychiatr Scand; 1982 Jul; 66(1):66-82. PubMed ID: 6181652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of zimelidine and desipramine on serotonin and noradrenaline uptake mechanisms in relation to plasma concentrations and to therapeutic effects during treatment of depression.
    Aberg-Wistedt A; Jostell KG; Ross SB; Westerlund D
    Psychopharmacology (Berl); 1981; 74(4):297-305. PubMed ID: 6457309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of neuropharmacologic selectivity in antidepressant action: fluvoxamine versus desipramine.
    Nathan RS; Perel JM; Pollock BG; Kupfer DJ
    J Clin Psychiatry; 1990 Sep; 51(9):367-72. PubMed ID: 2120201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between zimelidine and desipramine in endogenous depression. A cross-over study.
    Aberg-Wistedt A
    Acta Psychiatr Scand; 1982 Aug; 66(2):129-38. PubMed ID: 6215831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A double-blind comparison of zimelidine and desipramine in endogenous depression.
    Lingjaerde O; Bratfos O; Bratlid T; Haug JO
    Acta Psychiatr Scand; 1983 Jul; 68(1):22-30. PubMed ID: 6225313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alteration of norepinephrine metabolism with desipramine and zimelidine in depressed patients.
    Linnoila M; Karoum F; Calil HM; Kopin IJ; Potter WZ
    Arch Gen Psychiatry; 1982 Sep; 39(9):1025-8. PubMed ID: 6214234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Platelet serotonin uptake inhibition as a basis for monitoring antidepressant drug treatment.
    Lingjaerde O
    J Clin Psychopharmacol; 1984 Apr; 4(2):76-81. PubMed ID: 6231316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind comparison of zimelidine and amitriptyline in depressive out-patients.
    Syvälahti E; Salminen J; Lehtinen V
    J Int Med Res; 1982; 10(4):250-6. PubMed ID: 6214441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, double-blind comparison of duloxetine and venlafaxine in the treatment of patients with major depressive disorder.
    Perahia DG; Pritchett YL; Kajdasz DK; Bauer M; Jain R; Russell JM; Walker DJ; Spencer KA; Froud DM; Raskin J; Thase ME
    J Psychiatr Res; 2008 Jan; 42(1):22-34. PubMed ID: 17445831
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A double-blind evaluation of zimelidine in comparison to placebo and amitriptyline in patients with major depressive disorder.
    Claghorn J; Gershon S; Goldstein BJ; Behrnetz S; Bush DF; Huitfeldt B
    Prog Neuropsychopharmacol Biol Psychiatry; 1983; 7(2-3):367-82. PubMed ID: 6225150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controlled trial of zimelidine, a 5-HT reuptake inhibitor, for treatment of depression.
    Georgotas A; Krakowski M; Gershon S
    Am J Psychiatry; 1982 Aug; 139(8):1057-8. PubMed ID: 6211994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double blind comparison of zimelidine and amitriptyline in endogenous depression.
    Montgomery SA; McAuley R; Rani SJ; Roy D; Montgomery DB
    Acta Psychiatr Scand Suppl; 1981; 290():314-27. PubMed ID: 6452798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind study of zimelidine, a serotonin uptake inhibitor, and desipramine, a norepinephrine uptake inhibitor, in endogenous depression: clinical and biochemical findings.
    Aberg-Wistedt A; Ross SB; Jostell KG; Sjöquist B
    Adv Biochem Psychopharmacol; 1984; 39():439-47. PubMed ID: 6205564
    [No Abstract]   [Full Text] [Related]  

  • 17. Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness.
    Heel RC; Morley PA; Brogden RN; Carmine AA; Speight TM; Avery GS
    Drugs; 1982 Sep; 24(3):169-206. PubMed ID: 6215240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zimelidine: a placebo-controlled trial in depression.
    Norman TR; Burrows GD; Marriott PF; McIntyre IM; Davies BM; Moore RG
    Psychiatry Res; 1983 Feb; 8(2):95-103. PubMed ID: 6222387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crossover study of zimelidine and desipramine in depression: evidence for amine specificity [proceedings].
    Potter WZ; Calil HM; Extein I; Muscettola G; Goodwin FK
    Psychopharmacol Bull; 1981 Jan; 17(1):26-9. PubMed ID: 6453356
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of electroconvulsive therapy and desipramine on neuroendocrine responses to the clonidine challenge test.
    Coote M; Wilkins A; Werstiuk ES; Steiner M
    J Psychiatry Neurosci; 1998 May; 23(3):172-8. PubMed ID: 9595891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.